Humana Healthy Horizons Commits $4.6 Million to Improve Health of Ohioans

Community investments benefit eight organizations throughout Ohio COLUMBUS, Ohio–(BUSINESS WIRE)–Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana Inc. (NYSE: HUM), announced today that it has invested $4.6 million to support community organizations in Ohio that share the company’s passion for overcoming public health challenges and improving the health and well-being … [Read more…]

MIT-Northpond Program Created to Advance Innovation in Engineering and Life Science

CAMBRIDGE, Mass.–(BUSINESS WIRE)–MIT School of Engineering and Northpond Ventures today announced the launch of the MIT-Northpond Program – Advancing Life Science & Engineering Innovation. The five-year engagement is funded through Northpond Labs, the research and development-focused affiliate of Northpond Ventures. The program aims to generate ideas in the life sciences by connecting Northpond’s experienced venture … [Read more…]

Affini-T Therapeutics & Metagenomi Announce Next-Generation Gene Editing Partnership to Advance Cell Therapies for Solid Tumor Patients

BOSTON & SEATTLE & EMERYVILLE, Calif.–(BUSINESS WIRE)–Affini-T Therapeutics, Inc., a biotechnology company unlocking the power of T cells against oncogenic driver mutations, and Metagenomi, Inc., a genetic medicines company with a versatile portfolio of next-generation, wholly-owned gene editing tools, today announced a partnership to enable Affini-T’s next generation ex vivo T cell receptor (TCR) cell … [Read more…]

Women’s Brain Project and Altoida Announce Results Highlighting Sex-Based Differences Using Predictive Digital Biomarker in Alzheimer’s Disease

WASHINGTON–(BUSINESS WIRE)–#alzheimers—The Women’s Brain Project, an international non-profit organization studying gender and sex determinants to brain and mental health and Altoida, a precision neurology company pioneering non-invasive brain health diagnostics using AI and augmented reality (AR), today announced results from a study showing sex-based differences using digital biomarker data collected from Altoida’s digital cognitive assessment … [Read more…]

Avilar Therapeutics Appoints Adam Muzikant, PhD, as Chief Business Officer

WALTHAM, Mass.–(BUSINESS WIRE)–Avilar Therapeutics, a biopharmaceutical company focused on extracellular protein degradation, today announced the appointment of Adam Muzikant, PhD, as Chief Business Officer. Dr. Muzikant brings 18 years of business development experience creating and executing value-creating deals, from platform collaborations to commercial-stage product licenses and M&A, across a range of therapeutic areas and technologies … [Read more…]

Astrocyte Announces Initiation of First-In-Human Phase 1 Study of the Promising Stroke and Traumatic Brain Injury Therapeutic, AST-004

GROTON, Conn.–(BUSINESS WIRE)–Astrocyte Pharmaceuticals Inc., a drug discovery and development company advancing novel cerebroprotective therapeutics for patients with brain injuries, announced that the Company’s first-in-human Phase 1 clinical study initiated today with the dosing of a first subject with AST-004. The promising investigational therapeutic, AST-004, is being advanced as a potential acute treatment for stroke … [Read more…]

Walgreens and Greater Than AIDS Partner with Health Departments and Community Organizations to Provide Free HIV Testing and Information in More Than 250 Cities on National HIV Testing Day (June 27)

Largest Coordinated HIV Testing Event in the Nation DEERFIELD, Ill. & SAN FRANCISCO–(BUSINESS WIRE)–Walgreens and Greater Than AIDS, a public information initiative of KFF (Kaiser Family Foundation), are teaming up with health departments and community organizations in more than 250 cities to host the largest coordinated National HIV Testing Day (NHTD) event in the nation. … [Read more…]

Pear Therapeutics Announces Three New Board Members

New Board Members Paul Mango, Shiva Rajaraman, and Tim Wicks bring a depth of experience and knowledge in both the healthcare and technology industries BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the election of Paul Mango and Tim Wicks and the … [Read more…]

Flywheel to Serve as Research Platform for Understanding Pediatric Brain Development in Low- and Middle-Income Countries

Grant from Bill & Melinda Gates Foundation will fund research collaboration among 25 global sites MINNEAPOLIS–(BUSINESS WIRE)–Flywheel, the leading data management platform for biomedical research and collaboration, has received a grant from the Bill & Melinda Gates Foundation to support research on the neurodevelopmental health of children growing up in poverty and other adverse environments … [Read more…]

Antibe Therapeutics Announces Amendment to Warrant Terms

TORONTO–(BUSINESS WIRE)–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF) (the “Company“), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, announces that it is extending the expiry date (the “Warrant Extension”) and amending the exercise price (the “Amended Exercise Price”) of 3,117,957 common share purchase warrants (“Warrants”) of … [Read more…]